Codes / ICD10CM / C82.55

C82.55 Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Diffuse Follicle Center Lymphoma, Lymph Nodes of Inguinal Region and Lower Limb

Summary

Diffuse follicle center lymphoma is a type of non-Hodgkin lymphoma that originates in the lymphatic system, specifically affecting B-cells. It is characterized by the proliferation of cancerous lymphocytes, which can accumulate in lymph nodes and other tissues. When localized to the lymph nodes of the inguinal region and lower limb, it typically involves the inguinal, femoral, or other regional lymph node groups in this area. This condition may present with varying clinical behavior, ranging from indolent to more aggressive forms.

Causes

The exact cause of diffuse follicle center lymphoma is not fully understood, but it is associated with genetic mutations in B-cells. Environmental factors and immune system dysfunction may contribute to its development.

Risk Factors

  • Age: More common in individuals over 60.
  • Family history: A history of lymphoma can increase risk.
  • Immune system deficiencies.
  • Certain infections, such as hepatitis C.

Symptoms

  • Painless swelling of lymph nodes in the inguinal region or lower limb.
  • Fatigue.
  • Night sweats.
  • Unexplained weight loss.
  • Fever.

Diagnosis

Diagnosis involves a physical examination, medical history review, blood tests, imaging studies (e.g., CT or PET scans), and a biopsy of affected lymph nodes to confirm the presence and subtype of lymphoma.

Treatment Options

  • Watchful waiting: Monitoring the condition without immediate treatment if symptoms are mild.
  • Radiation therapy: Targeted treatment for localized disease.
  • Chemotherapy: Systemic treatment for more extensive or aggressive disease.
  • Immunotherapy: Targeted therapies to enhance the immune system's ability to fight cancer.
  • Stem cell transplant: Considered for relapsed or refractory cases.

Prognosis and Follow-Up

Prognosis depends on factors such as the stage of the disease, overall health, and response to treatment. Regular follow-up with imaging and clinical assessments is essential to monitor for recurrence or progression.

Complications

  • Disease progression or transformation to a more aggressive subtype.
  • Infection due to compromised immune function.
  • Lymphedema from lymph node involvement or treatment.
  • Treatment-related side effects (e.g., fatigue, nausea, or organ toxicity).

Lifestyle & Prevention

  • Maintain a balanced diet and regular exercise to support overall health.
  • Avoid known carcinogens and manage chronic infections.
  • Stay up-to-date with vaccinations to reduce infection risk.
  • Seek prompt medical attention for persistent symptoms.

When to Seek Professional Help

Consult a healthcare provider if you experience persistent lymph node swelling, unexplained weight loss, night sweats, or fatigue. Early evaluation is important for timely diagnosis and management.

Tips for Medical Coders

Use code C82.55 for diffuse follicle center lymphoma specifically involving the lymph nodes of the inguinal region and lower limb. Ensure documentation specifies the anatomical location to support accurate coding. Review clinical notes for confirmation of the lymphoma subtype and site to avoid miscoding.

Book a walkthrough

C82.55 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.